Rapamycin and thalidomide treatment of a patient with refractory metastatic gastroesophageal adenocarcinoma: a case report.
Ong
Sin Jen
SJ
Department of Medical Oncology, National Cancer Centre Singapore, Singapore. ongsinjen@yahoo.com
Teo
Marissa
M
Lim
Kiat Hon
KH
Choo
Su Pin
SP
Toh
Han Chong
HC
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D004943:Esophagogastric Junction; D006801:Humans; D008297:Male; D010766:Phosphorylation; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D020123:Sirolimus / Q000008:administration & dosage; D013274:Stomach Neoplasms / Q000188:drug therapy*; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism; D013792:Thalidomide / Q000008:administration & dosage
D018719:Erb-b2 Receptor Tyrosine Kinases; D020123:Sirolimus; D058570:TOR Serine-Threonine Kinases; D013792:Thalidomide; C546842:MTOR protein, human; C508053:ERBB2 protein, human
Cancer Res. 2008 Apr 15;68(8):2632-40
18413730
Aliment Pharmacol Ther. 2003 Mar 1;17(5):677-82
12641516
Blood. 2004 Dec 15;104(13):4188-93
15319277
J Clin Pathol. 2008 Aug;61(8):909-13
18474542
J Hepatol. 2008 Jul;49(1):52-60
18490075
Clin Cancer Res. 2009 Mar 1;15(5):1821-9
19223493
J Clin Oncol. 2010 Apr 10;28(11):1904-10
20231677
Palliat Med. 2009 Jul;23(5):473-5
19304809
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4082-5
7513432
Clin Cancer Res. 2009 Dec 1;15(23):7266-76
19934303
Biochim Biophys Acta. 2010 Apr;1803(4):435-42
20116405
Surgery. 1999 May;125(5):536-44
10330943
Int J Cancer. 2007 Apr 15;120(8):1803-10
17230506